Evidence map›Paper›PMID 40111048›Full record

ArticlemBio2025

Defense arsenal of the strict anaerobe

Aurélie Lotoux, Léo Caulat, Catarina Martins Alves, Carolina Alves Feliciano, Claire Morvan, Filipe Folgosa, Isabelle Martin-Verstraete

Abstract read
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Journal of bacteriology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aurélie LotouxInstitut Pasteur, Université Paris Cité, UMR CNRS 6047, Laboratoire Pathogenèse des Bactéries Anaérobies, Paris, Île-de-France, France.ORCID 0000-0002-3956-778X
Léo CaulatInstitut Pasteur, Université Paris Cité, UMR CNRS 6047, Laboratoire Pathogenèse des Bactéries Anaérobies, Paris, Île-de-France, France.ORCID 0000-0002-5940-2990
Catarina Martins AlvesInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Lisbon, Portugal.
Carolina Alves FelicianoInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Lisbon, Portugal.
Claire Morvan *Institut Pasteur, Université Paris Cité, UMR CNRS 6047, Laboratoire Pathogenèse des Bactéries Anaérobies, Paris, Île-de-France, France.ORCID 0000-0001-8435-0523
Filipe Folgosa *Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Lisbon, Portugal.ORCID 0000-0001-5879-151X
Isabelle Martin-VerstraeteInstitut Pasteur, Université Paris Cité, UMR CNRS 6047, Laboratoire Pathogenèse des Bactéries Anaérobies, Paris, Île-de-France, France.ORCID 0000-0002-8376-7690

Funding

Agence Nationale de la Recherche ANR-22-CE15-0026-01LS4Future associated Laboratory LA/P/0087/2020Portuguese FCT PTDC/BIA-BQM/0562/2020Portuguese FCT UI/BD/154601/2022Portuguese FCT UIDB/04612/2020Portuguese FCT UIDP/04612/2020
6 · The paper itself

Abstract

IMPORTANCE: ROS plays a fundamental role in intestinal homeostasis, limiting the proliferation of pathogenic bacteria.

Indexed as

Clostridioides difficileClostridium InfectionsReactive Oxygen SpeciesBacterial ProteinsGene Expression Regulation, BacterialHydrogen PeroxideOxidative StressOxidoreductasesBacterial ProteinsHydrogen PeroxideOxidoreductasesReactive Oxygen SpeciesperoxidasePerRrubrerythrinSigma BSpxstress responsesuperoxide reductase

Identifiers

PMID40111048
PMCPMC11980386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.